一个读者YTHDF3通过YTHDF3/m6 A-EGFR/STAT3轴和EMT触发肝细胞癌的进展
Bowen Hu1,2,3,4, Jie Gao2,3,4, Jihua Shi2,3,4
1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
通过稳定表皮生长因子受体 (EGFR) mRNA,YTHDF3促进肝细胞癌 (HCC) 的进展. 这一发现表明YTHDF3是治疗HCC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- N6-甲基氨酸 (m6 A) 修饰影响瘤生物学.
- 在HCC中,m6 A读者YTHDF3的作用在很大程度上是未知的.
研究的目的:
- 调查YTHDF3在HCC进展中的致癌作用.
- 阐明YTHDF3影响HCC的机制,重点关注m6A修饰mRNAs的表观遗传调节.
主要方法:
- 西部斑块,免疫组织化学和qRT-PCR用于评估HCC组织中的YTHDF3表达.
- 在体外和体内实验中评估YTHDF3对HCC细胞增殖,入侵和迁移的功能影响.
- 对下游信号通路的分析,包括EGFR/STAT3和EMT.
主要成果:
- 在HCC组织中,YTHDF3的表达显著升高,特别是在微血管入侵的情况下.
- YTHDF3的过度表达增强了HCC细胞的增殖,入侵和迁移,而敲击抑制了这些过程.
- YTHDF3稳定和增强m6A修饰表皮生长因子受体 (EGFR) mRNA的翻译,激活EGFR/STAT3和EMT通路.
结论:
- YTHDF3通过促进通过m6轴A-EGFR-STAT3/EMT的瘤进展,作为HCC中的瘤基因.
- YTHDF3代表了一种有前途的新型治疗点,用于肝细胞癌治疗.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
